Table 1.

Baseline patient demographic characteristics

Variable	Value (n = 13)
Mean (range) age (years)	64 (47–80)
No. (%) male	9 (69)
No. (%) site of primary lesion (%)
Pancreas	5 (39)
Other (rectum, ovary, small bowel)	4 (31)
Unknown	4 (31)
No. (%) ECOG performance status
0	7 (54)
1	6 (46)
Tumor (%) burden (range)	4–75
Tumor size (SD) mean largest index (cm)	5.9
Treated with Sandostatin at baseline (%)	5 (38)
Previous therapy for hepatic neuroendocrine metastases
Chemotherapy	0
External radiation (%)	2 (15)
Carcinoid syndrome (%)	3 (23)
Chromogranin A: no. diagnostic (ng/mL)	10 (1,037.46)
5-HIAA: no. (mean) diagnostic (mg/24 h)	6 (149)

5-HIAA 5-Hydroxyindoleacetic acid